Natural killer (NK) cells and interleukin-2 activated NK cells, termed
lymphokine-activated killer (LAK) cells, can lyse tumor cells without
restriction by the MHC complex. The cytotoxic activity of these cells
is subject to regulation by nonlymphoid cells in vitro. Interaction o
f NK cells with red blood cells (RBC) increases NK cytotoxicity. Inter
action with polymorphonuclear neutrophils (PMN) suppresses LAK develop
ment and also inhibits NK- and LAK-mediated cytotoxicity at the effect
or cell phase. Exposure to tumor necrosis factor-a greatly enhances th
e inhibitory effect of PMN at the effector cell phase. Depending on th
eir states of activation and differentiation, monocytes have the capac
ity to either enhance or suppress LAK induction. In contrast, macropha
ges derived from the lung are potent inhibitors of NK and LAK activity
at both the induction and effector cell phases. Several cytokines are
secreted by monocytes and macrophages and these include both suppress
ive and enhansive factors of cytotoxic function. Platelets are also ca
pable of releasing suppressive factors. NK cells are believed to be in
volved in host surveillance of tumors, control of microbial infections
and regulation of hematopoiesis. Regulation of NK cells by nonlymphoi
d cells and their products likely provides an in vivo mechanism for lo
cally regulating NK function.